LH moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on LH as a result. In 60 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for LH just turned positive on October 08, 2026. Looking at past instances where LH's MACD turned positive, the stock continued to rise in 24 of 52 cases over the following month. The odds of a continued upward trend are 46%.
Following a +1.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where LH advanced for three days, in 192 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 58 cases where LH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 60%.
The 10-day moving average for LH crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
LH broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LH entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.045) is normal, around the industry mean (64.051). P/E Ratio (26.551) is within average values for comparable stocks, (1.569). Projected Growth (PEG Ratio) (1.206) is also within normal values, averaging (3.473). LH has a moderately high Dividend Yield (0.009) as compared to the industry average of (0.002). P/S Ratio (1.876) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. LH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
SYK moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on SYK as a result. In 50 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for SYK just turned positive on September 28, 2026. Looking at past instances where SYK's MACD turned positive, the stock continued to rise in 22 of 44 cases over the following month. The odds of a continued upward trend are 50%.
Following a +3.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where SYK advanced for three days, in 171 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
SYK broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SYK entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. SYK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.867) is normal, around the industry mean (2.979). P/E Ratio (31.285) is within average values for comparable stocks, (2.590). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (11.052). Dividend Yield (0.012) settles around the average of (0.009) among similar stocks. P/S Ratio (4.259) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SYK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
LH | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 36 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 47 | 76 | |
SMR RATING 1..100 | 65 | 52 | |
PRICE GROWTH RATING 1..100 | 42 | 55 | |
P/E GROWTH RATING 1..100 | 62 | 83 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LH's Valuation (11) in the Servicestothe Health Industry industry is somewhat better than the same rating for SYK (75) in the Medical Specialties industry. This means that LH’s stock grew somewhat faster than SYK’s over the last 12 months.
LH's Profit vs Risk Rating (47) in the Servicestothe Health Industry industry is in the same range as SYK (76) in the Medical Specialties industry. This means that LH’s stock grew similarly to SYK’s over the last 12 months.
SYK's SMR Rating (52) in the Medical Specialties industry is in the same range as LH (65) in the Servicestothe Health Industry industry. This means that SYK’s stock grew similarly to LH’s over the last 12 months.
LH's Price Growth Rating (42) in the Servicestothe Health Industry industry is in the same range as SYK (55) in the Medical Specialties industry. This means that LH’s stock grew similarly to SYK’s over the last 12 months.
LH's P/E Growth Rating (62) in the Servicestothe Health Industry industry is in the same range as SYK (83) in the Medical Specialties industry. This means that LH’s stock grew similarly to SYK’s over the last 12 months.
| LH | SYK | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 58% |
| Stochastic ODDS (%) | 1 day ago 60% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 60% | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 46% | 1 day ago 50% |
| TrendWeek ODDS (%) | 1 day ago 58% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 50% |
| Advances ODDS (%) | 1 day ago 57% | 1 day ago 56% |
| Declines ODDS (%) | 21 days ago 53% | 8 days ago 52% |
| BollingerBands ODDS (%) | 1 day ago 49% | 1 day ago 57% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 39% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LH’s FA Score shows that 1 FA rating(s) are green while SYK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LH’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).
LH (@Medical Specialties) experienced а +3.03% price change this week, while SYK (@Medical/Nursing Services) price change was +7.73% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.69%. For the same industry, the average monthly price growth was -4.76%, and the average quarterly price growth was +43.77%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.03%. For the same industry, the average monthly price growth was -9.14%, and the average quarterly price growth was -10.41%.
LH is expected to report earnings on Oct 28, 2026.
SYK is expected to report earnings on Oct 29, 2026.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+0.03% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, LH has been closely correlated with DGX. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if LH jumps, then DGX could also see price increases.
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.